Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda.
about
Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapyValidation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.Measures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals.HIV/AIDS Clinical Manifestations and their Implication for Patient Clinical Staging in Resource Limited Settings in Tanzania.Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa.Evaluation of PIMATM CD4 System for Decentralization of Immunological Monitoring of HIV-Infected Patients in Senegal.Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi.A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting.Commentary: Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step.
P2860
Q28730448-345AFD98-6CA0-44E6-9B3D-458323D77C82Q31010477-BEC2BFA4-DA9C-4E32-A70A-235FCDB65114Q33492607-A44DD882-59E1-471F-8773-B843E5ACEDE1Q33755986-DD28F61B-0D7D-4CA4-B3C7-CD31A4BFE450Q33813587-4F6FAA88-57EA-432A-941F-6C109B06EB0BQ35012921-5FC97D06-98BD-4B28-93E7-5DCF14FC9DB9Q35116098-B7D93EF3-0169-4D4A-9BC1-49D60EF88DA2Q35154857-C769CC13-7DDF-475A-AD14-38BA35859897Q36014143-62D12FB7-D656-4948-92E4-D6A91B2E425CQ36043429-F72DBA04-11CD-4D82-8570-FACF7A005851Q37664992-1C0A9FA6-3A69-44B5-B51A-E12AD33EDD97Q39162558-C2F698F0-FE38-49B5-A821-FFACC07DD56B
P2860
Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Use of WHO clinical stage for ...... vice setting in Jinja, Uganda.
@ast
Use of WHO clinical stage for ...... vice setting in Jinja, Uganda.
@en
type
label
Use of WHO clinical stage for ...... vice setting in Jinja, Uganda.
@ast
Use of WHO clinical stage for ...... vice setting in Jinja, Uganda.
@en
prefLabel
Use of WHO clinical stage for ...... vice setting in Jinja, Uganda.
@ast
Use of WHO clinical stage for ...... vice setting in Jinja, Uganda.
@en
P2093
P2860
P921
P356
P1476
Use of WHO clinical stage for ...... vice setting in Jinja, Uganda.
@en
P2093
Alex Coutinho
Barbara Amuron
Christine Nabiryo
Geoffrey Namara
Josephine Birungi
P2860
P2888
P356
10.1186/1742-6405-5-4
P577
2008-02-28T00:00:00Z
P5875
P6179
1033756483